您现在的位置: 首页> 研究主题> 结肠直肠肿瘤

结肠直肠肿瘤

结肠直肠肿瘤的相关文献在1995年到2021年内共计698篇,主要集中在肿瘤学、外科学、基础医学 等领域,其中期刊论文696篇、会议论文1篇、专利文献48261篇;相关期刊167种,包括腹部外科、中华胃肠外科杂志、中华外科杂志等; 相关会议1种,包括第十二次全国中西医结合医学影像学术研讨会等;结肠直肠肿瘤的相关文献由2195位作者贡献,包括郑民华、李世拥、陆爱国等。

结肠直肠肿瘤—发文量

期刊论文>

论文:696 占比:1.42%

会议论文>

论文:1 占比:0.00%

专利文献>

论文:48261 占比:98.58%

总计:48958篇

结肠直肠肿瘤—发文趋势图

结肠直肠肿瘤

-研究学者

  • 郑民华
  • 李世拥
  • 陆爱国
  • 于波
  • 安萍
  • 李健文
  • 冯波
  • 王明亮
  • 郑树
  • 马君俊
  • 期刊论文
  • 会议论文
  • 专利文献

搜索

排序:

年份

    • 马瑞雅; 程健; 吴昊阳; 张学明
    • 摘要: 结直肠癌(CRC)在我国发病率和死亡率逐年升高,而免疫检查点抑制剂治疗为CRC患者带来了新选择.现阶段免疫治疗获益人群仅局限于微卫星高度不稳定(MSI-H)的CRC群体,现有免疫治疗中,无论是抗程序性死亡配体1(PD-L1)单抗单药使用还是联合抗细胞毒性T淋巴细胞相关抗原4(CTLA4)免疫点抑制剂联合用药,对于微卫星稳定(MSS)CRC群体均无明显疗效.结合唾液酸免疫球蛋白型凝集素-15(Siglec-15)正常情况下仅在某些髓样细胞上表达,但在人类癌细胞和肿瘤浸润性髓样细胞表达广泛上调.最新研究显示,Siglec-15有望成为当前免疫治疗肿瘤患者的全新靶点,可为抗PD-L1治疗无效的MSS型CRC患者带来免疫治疗新希望.本文旨在阐述Siglec-15自身在肿瘤方面最新研究进展及CRC免疫治疗的研究近况,对Siglec-15在CRC免疫治疗方面的研究进行阐述,以期为CRC免疫治疗提供参考信息.
    • Shi Chengren; Cai Wei; Zhang Zhongde; Wu Yeming; Wu Zhixiang; Cui Long; Guan Wenbin; Wang Lifeng; Yin Minzhi; Gong Yiming
    • 摘要: Objective To retrospectively review the clinical manifestations,pathological characteristics and outcomes of colorectal carcinoma and compare them with those of adults.Methods Between January 2010 and January 2016,3401 patients with colorectal carcinoma were hospitalized.There were 4 boys and 2 girls with a mean age of 13 years.Six of them (0.17%) were aged under 14 years.All diagnoses were confirmed by pathological examination.Two age groups of adult patients were randomly sampled 20-30 years (n=17) and 50-60 years (n=67) and their clinical presentations and pathological characteristics were compared with those of adults.Results The presenting manifestations included abdominal pain,hematochezia,abdominal mass,intestinal obstruction,and change in frequency/form of stool.Tumor locations included colon (n=5) and rectum (n=1).The pathological diagnoses were mucinous adenocarcinoma (n=2),signet-ring cell carcinoma (n=3) and ductal carcinoma (n=1).Metastasis was regional lymphatic (n=5) and distant (n=1).One case had intestinal neuronal dysplasia while another was operated plus adjuvant chemotherapy for hepatoblastoma 10 years previously.Three of them received chemotherapy.Until 30 August 2016,there were death (n=3),lost to follow-up (n=1) and survival (n=2).Two survivors had a worse quality of life than healthy controls.The adult dominant presenting symptom was altered stool habit.Their pathological diagnoses were ductal carcinoma,poorly differentiated adenocarcinoma,signetring cell carcinoma and mucinous adenocarcinoma in those aged 20-30 years versus ductal carcinoma,mucinous adenocarcinoma,papillary tubular adenocarcinoma,poorly differentiated adenocarcinoma and undifferentiated cancer in those aged 50-60 years.Conclusions Pediatric colorectal carcinoma is extremely rare and our reviewed cases account for 0.17% of all reported cases.The clinical presentations are similar for children and adults.However,children present predominantly with recurrent abdominal pain,hematochezia,abdominal mass,intestinal obstruction and rarely alteration in stool habit,whereas this is the commonest presenting symptom in adults.Most tumors are located in colon.Mucinous adenocarcinoma and signet-ring cell carcinoma are the major pathological diagnoses in children.And most of them have regional lymphatic metastases while ductal carcinoma is more common in adults.%目的 回顾性分析6例儿童结、直肠恶性肿瘤患儿的临床表现、病理特征及疾病转归,同时寻找与成人临床病理不同点.方法 回顾性分析2010年1月至2016年1月共收治的结、直肠癌患儿共3 401例,其中<14岁以下6例,占0.17%.男4例,女2例,平均年龄13岁,均经病理检查证实.同时在同期20 ~ 30岁年龄组和50 ~ 60岁年龄组中采用随机数字表法随机抽样分别产生17例和67例病例,分别与儿童结、直肠癌临床表现、病理特征做一比较.结果 临床表现以腹痛、便血、腹部肿块、肠梗阻为主,1例有大便习性改变.病理特征:肿瘤部位在结肠5例,直肠1例.病理诊断:结肠黏液腺癌2例,印戒细胞癌3例,管状腺癌1例,均有区域性淋巴结转移,1例远处转移.病理检查中还发现1例合并肠神经元发育异常改变(例6).例2十年前曾做肝母细胞瘤切除,辅以化疗,此为二次肿瘤.6例儿童均予以化疗,至随访日(2016年8月30日)有3例死亡,1例失随访,2例存活,继续化疗中.后者生活质量低于同龄儿童.对照20~30岁年龄组,与50~60岁年龄组,后二组临床表现则以大便习性改变为主.从病理特征分析,20~30岁组以管状腺癌、低分化腺癌、印戒细胞癌、黏液腺癌(以多少排序)多见,50~60岁组以管状腺癌、黏液腺癌、乳头状管状腺癌、低分化腺癌、未分化癌(以多少排序)多见.结论 儿童结、直肠癌罕见,本组6例占全年龄段结、直肠癌数中0.17%.临床表现仍与成年人结、直肠癌相似,但首发症状以反复腹痛、便血、腹部肿块、肠梗阻为主,大便习性改变少见.而成年人结、直肠癌则以大便习性改变为主.儿童结肠部位多见,以黏液腺癌和印戒细胞癌为主,大多有周边淋巴转移.成年组以管状腺癌为主,儿童结肠癌有肠神经元发育异常.
    • 胡荣; 翁延宏; 刘爱彬
    • 摘要: 目的 探讨在加速康复外科(ERAS)理念指导下的多模式镇痛模式对结肠、直肠肿瘤术后应激反应、临床结局的影响.方法 选取结肠、直肠肿瘤手术患者,根据术后镇痛方式分为常规镇痛组与多模式镇痛组,比较2组患者术后应激反应、术后胃肠功能恢复情况及住院结局的差异.结果 2组患者一般资料比较,差异无统计学意义(P>0.05).与常规镇痛组比较,多模式镇痛组患者的术后白细胞和C反应蛋白显著降低,术后胃肠功能恢复显著提前,住院时间显著缩短,差异均有统计学意义(P<0.05).结论 加速康复外科理念指导下的多模式镇痛可显著减轻结肠、直肠肿瘤术后患者的应激反应,并能有效促进术后肠功能恢复.
    • 曹金玉; 张德元; 刘繁荣
    • 摘要: 消化系统肿瘤是最常见的恶性肿瘤之一,其发生、发展机制尚不清楚是影响肿瘤治疗的重要原因.研究表明RNA在消化系统肿瘤的转录后调控机制中发挥重要的作用,ln-cRNA、mRNA、假基因转录物、环状RNA等各类RNA分子,仅需相同的miRNA应答元件,就可竞争性结合相同的miRNA调控靶基因,从而调节各自的表达.这些RNA分子互为竞争性内源性RNA(competing endogenous RNA,ceRNA).该文着重探讨ceRNA假说及其在消化系统恶性肿瘤中的研究进展,并展望其研究前景.
    • 李庆华
    • 摘要: 目的:探讨多层螺旋CT(MSCT)结直肠充气成像技术的临床应用.方法:选取我院自2015年4月至2016年10月的35例行MSCT检查的患者作为此次研究的观察对象,依据肿瘤影像诊断价值对MSCT结直肠充气成像技术的临床应用与价值进行分析与探讨.结果:本次研究选取的35例患者中未发现占位性病变者共9例,MSCT诊断为结肠癌者17例,其中9例已经手术验证,所有患者均经1次扫描即可获得理想图像.结论:MSCT结直肠充气成像技术操作简单,成功率高.
    • 陈万源; 鞠海星; 吴伟; 胡锦林; 李德川
    • 摘要: 目的探讨不同部位Ⅲ期结直肠癌患者的临床病理及错配修复基因表达的的差异.方法应用En-Vision二步法检测340例结直肠癌中hMLH1、hMSH2和hMSH6的表达,并分析不同部位结直肠癌的临床病理及hMLH1、hMSH2、hMSH6的差异.结果340例Ⅲ期结直肠癌中,右半结肠、左半结肠和直肠癌分别为60、68和212例,肿瘤侵润深度、肿瘤细胞分化程度在右半结肠、左半结肠和直肠癌中均有统计学差异(均P<0.05),而患者年龄、性别、淋巴结转移数在不同部位肿瘤中均无统计学差异(均P>0.05).在右半结肠、左半结肠和直肠癌中hMLH1表达缺失率分别为13.4%、2.9%和57%,差异有统计学意义(P<0.05);hMSH2分别为6.7%、1.5%和47%,差异有统计学意义(P<0.05);hMSH6分别为3.3%、2.9%和1.9%,差异无统计学意义(P>0.05);MMR(hMLH1+hMSH2+ hMSH6)分别为23.3%、7.4%和11.8%,差异有统计学意义(P<0.05).结论不同部位的Ⅲ期结直肠癌中,其临床病理及hMLH1、hMSH2、hMSH6差异明显.
    • 杨芬; 魏磊; 王幸双; 赵建华
    • 摘要: 目的:比较结肠、直肠肿瘤腔镜手术中连续硬膜外复合静脉麻醉,全凭静脉麻醉和全凭吸入麻醉对患者血浆促炎性细胞因子IL-17和IL-23的影响。方法患者随机分成3组( n=20):连续硬膜外复合静脉麻醉组(A组):布比卡因连续硬膜外泵注维持麻醉,复合丙泊酚静脉泵注镇静;全凭静脉麻醉组(B组):术中静脉泵注丙泊酚镇静,芬太尼镇痛;全凭吸入麻醉组( C组):术中吸入笑气、氧气和七氟烷维持麻醉。 ELISA法检测血浆细胞因子IL-17和IL-23浓度。结果麻醉诱导前(T0)三组患者血浆IL-17和IL-23浓度处于高水平,且三组间无明显差异(P>0.05);与T0相比,手术开始后60 min(T1)、术后30 min(T2)和术后24 h(T3)三组患者血浆IL-17和IL-23浓度明显降低,其中T1时上述指标明显低于T2和T3时,T2时明显低于T3时( P<0.05);与C组相比,A、B组两组患者在T1、T2两时间点血浆IL-17和IL-23浓度明显降低,且A组上述指标明显低于B组( P<0.05);而在T3时间点三组无明显差异( P>0.05)。结论三种麻醉方法均可明显降低 IL-17和IL-23浓度,故对结直肠肿瘤患者有抑制促炎性反应作用,其中连续硬膜外复合静脉麻醉好于全凭静脉麻醉,全凭静脉麻醉好于全凭吸入麻醉。%Objective To compare the effects of continuous epidural block with intravenous anesthe-sia, total intravenous anesthesia and total inhalational anesthesia on pro-inflammatory cytokines IL-17 and IL-23 serum levels in patients undergoing colorectal cancer laparoscopic surgery .Methods All the pa-tients were randomly divided into 3 groups ( n=20 ):continuous epidural block combined intravenous an-esthesia group ( A group ):patients received continuous epidural anesthesia of bupivacaine , and received intravenous anesthesia with propofol;total intravenous anesthesia group ( B group):patients received total intravenous anesthesia with propofol and fentanil;total inhalational anesthesia group ( C group ): patients received total inhalational anesthesia with sevoflurane in O 2 and Nitrous Oxide .Serum levels of IL-17 and IL-23 were quantified .Results In the three groups ,levels of IL-17 and IL-23 were high prior to induc-tion of anesthesia(T0),and there was no difference between three groups (P>0.05).Compared with T0, levels of IL-17 and IL-23 significantly decreased at 60 min after the start of surgery ( T1 ) ,30 min post-surgery(T2) and 24 h post-surgery(T3);Levels of IL-17 and IL-23 were significantly lower at T1 than T2 and T3,and they were significantly lower at T2 than T3(P0 .05 ) .Con-clusions Levels of IL-17 and IL-23 significantly decrease in patients received the three anesthetic tech-niques,so it could attenuate pro-inflammation of patients undergoing colorectal cancer laparoscopic surgery .In this respect , continuous epidural block combined with intravenous anesthesia is the best .Total intravenous anesthesia is better than total inhalational anesthesia .
    • 杨芬; 魏磊; 王幸双; 赵建华
    • 摘要: 目的比较结肠、直肠肿瘤腔镜手术中连续硬膜外复合静脉麻醉,全凭静脉麻醉和全凭吸入麻醉对患者血浆促炎性细胞因子IL-17和IL-23的影响。方法患者随机分成3组(n=20):连续硬膜外复合静脉麻醉组(A组):布比卡因连续硬膜外泵注维持麻醉,复合丙泊酚静脉泵注镇静;全凭静脉麻醉组(B组):术中静脉泵注丙泊酚镇静,芬太尼镇痛;全凭吸入麻醉组(C组):术中吸入笑气、氧气和七氟烷维持麻醉。ELISA法检测血浆细胞因子IL-17和IL-23浓度。结果麻醉诱导前(T0)三组患者血浆IL-17和IL-23浓度处于高水平,且三组间无明显差异(P〉0.05);与T0相比,手术开始后60 min(T1)、术后30 min(T2)和术后24 h(T3)三组患者血浆IL-17和IL-23浓度明显降低,其中T1时上述指标明显低于T2和T3时,T2时明显低于T3时(P〈0.05);与C组相比,A、B组两组患者在T1、T2两时间点血浆IL-17和IL-23浓度明显降低,且A组上述指标明显低于B组(P〈0.05);而在T3时间点三组无明显差异(P〉0.05)。结论三种麻醉方法均可明显降低IL-17和IL-23浓度,故对结直肠肿瘤患者有抑制促炎性反应作用,其中连续硬膜外复合静脉麻醉好于全凭静脉麻醉,全凭静脉麻醉好于全凭吸入麻醉。
    • 胡继东; 吴波
    • 摘要: 目的:分析基层医院腹腔镜结直肠癌根治术中转开腹手术的原因。方法对2004年8月至2014年2月在该院完成腹腔镜结直肠癌根治术69例患者中15例中转开腹手术患者的原因进行分析。结果因术中腹腔内出血中转开腹手术9例,因肿瘤较大与周围组织浸润、分离困难中转开腹手术3例,因腹内脏器损伤中转开腹手术1例,因高碳酸血症中转开腹手术1例,因患者肥胖中转开腹手术1例。15例中转开腹手术的患者手术均顺利,术后无并发症出现,均顺利出院。结论腹腔镜结直肠癌术中转开腹手术的最主要原因为术中出血,而肿瘤较大、腹腔内脏器损伤也是诱发因素之一。严谨的术前评估、术者在实际腹腔镜手术水平中的合理估计是降低中转率的主要措施。
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号